Phico Therapeutics' Other Investors

Phico Therapeutics raised a round of funding on , .

Phico Therapeutics is developing SASPject PT3.8, an antibacterial therapy for the systemic treatment of patients with serious Pseudomonas aeruginosa (P. aeruginosa) infections, which have a high morta…

Articles about Phico Therapeutics' Other Investors: